Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies.

Journal of reproductive immunology - 1 Nov 2010

Martínez-Zamora M Angeles, Tassies Dolors, Carmona Francisco, Espinosa Gerard, Cervera Ricard, Reverter Juan Carlos, Balasch Juan

Abstract excerpt

We investigated clot lysis time, thrombin activatable fibrinolysis inhibitor antigen (TAFI) levels and TAFI gene polymorphisms in pregnant patients with severe preeclampsia, with or without associated antiphospholipid syndrome (APS). The study groups included 82 pregnant patients without antiphospholipid antibodies with severe preeclampsia (PE group) and 10 pregnant APS patients who developed severe preeclampsia...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antiphospholipid
Share to Antiphospholipid Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Coagulation Tests

Share to Carboxypeptidase B2

Share to Fibrinolysis

Share to Postpartum Period

Share to Pre-Eclampsia

Share to Pregnancy

Source

Identifiers

PMID: 20594598
DOI: 10.1016/j.jri.2010.05.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies.PMID 20594598Read ↗

High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke.Semantic proximity Read ↗

Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.Semantic proximity Read ↗

A new functional assay of thrombin activatable fibrinolysis inhibitor.Semantic proximity Read ↗

Plasminogen activator inhibitor-2 and impaired fibrinolysis in pregnancy and sickle cell anemia.Semantic proximity Read ↗

Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G.Semantic proximity Read ↗

Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism (TAFI1040C/T) in Women With Recurrent Spontaneous Abortion.Semantic proximity Read ↗

Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome.Semantic proximity Read ↗

Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris.Semantic proximity Read ↗

Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndromeSemantic proximity Read ↗

Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and embryo transfer.Semantic proximity Read ↗

Plasma levels of unactivated thrombin activatable fibrinolysis inhibitor (TAFI) are down-regulated in young adult women: analysis of a normal Japanese population.Semantic proximity Read ↗

Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.